• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SPYGLASS DISCOVER DIGITAL CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SPYGLASS DISCOVER DIGITAL CATHETER Back to Search Results
Model Number M00546780
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Inflammation (1932)
Event Date 02/11/2022
Event Type  Injury  
Manufacturer Narrative
Pro code: ntn.Initial reporter address: (b)(6).The device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation that a spyglass discover digital catheter was used during a percutaneous transhepatic cholangiography (ptc) procedure on (b)(6) 2022.The patient was enrolled in the spyglass discover percutaneous study no.(b)(6).During the procedure, the spyglass discover advanced to the target and target lesions/stones were visualized.A guidewire was used to assist the advancement of the spyglass discover during the ptc.Mechanical, electrohydraulic or laser clearance of biliary stones/sludge was completed and an intraductal drain remained in place for the safety of the subject.On (b)(6) 2022, the patient experienced cholangitis and was hospitalized and treated with antibiotic therapy.A cholangiography was also performed on (b)(6) 2022, but no residual lithiasis was observed.The biliary drainage was replaced and the patient was reported to be fine after receiving antibiotic therapy.
 
Event Description
It was reported to boston scientific corporation that a spyglass discover digital catheter was used during a percutaneous transhepatic cholangiography (ptc) procedure on february 10, 2022.The patient was enrolled in the spyglass discover percutaneous study no.(b)(6).During the procedure, the spyglass discover advanced to the target and target lesions/stones were visualized.A guidewire was used to assist the advancement of the spyglass discover during the ptc.Mechanical, electrohydraulic or laser clearance of biliary stones/sludge was completed and an intraductal drain remained in place for the safety of the subject.On (b)(6) 2022, the patient experienced cholangitis and was hospitalized and treated with antibiotic therapy.A cholangiography was also performed on (b)(6) 2022, but no residual lithiasis was observed.The biliary drainage was replaced and the patient was reported to be fine after receiving antibiotic therapy.Additional information was received on june 17, 2022: the physician stated that it is typical to hospitalize patients as standard of care for four to five days and that there was no delayed discharge due to the event.
 
Manufacturer Narrative
Block d2b: pro code ntn.Block e1: initial reporter address: gastroenterology & digestive endoscopy endoscopy agostino gemelli irccs.Correction: block h6 (patient codes): the patient code e2326 captures the reportable event of patient cholangitis.Block h6 (evaluation conclusion codes): conclusion code d17 is being used in lieu of an adequate conclusion code for device not returned.Block h10: the device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.Block h11 additional information: block b2 (outcomes attrib to adv event), block b5 (describe event or problem).Block h6 (impact codes).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPYGLASS DISCOVER DIGITAL CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
780 brookside drive
spencer IN 47460
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key13594951
MDR Text Key288027486
Report Number3005099803-2022-01010
Device Sequence Number1
Product Code FBN
UDI-Device Identifier08714729994183
UDI-Public08714729994183
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
K200483
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/13/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/10/2023
Device Model NumberM00546780
Device Catalogue Number4678
Device Lot Number0027281908
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/11/2022
Initial Date FDA Received02/24/2022
Supplement Dates Manufacturer Received06/17/2022
Supplement Dates FDA Received07/13/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/10/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age69 YR
Patient SexFemale
-
-